Highlights
==========

-   Light anesthesia affects food intake.

-   Exposure to light anesthetic agents affect the glucosensing and dopaminergic neurons.

-   Feeding experimental results may be affected by any experimental approach using light anesthetic agents.

Plain Language Summary
======================

Carbon dioxide and diethyl ether are used as light anesthetic agents in many experimental approaches. However, experimental data about their side effects are scarce. We found that light CO~2~ but not diethyl ether decreases food intake. Our results demonstrate that hypothalamic neurons may be, at least in part, one of the targets of light anesthetic agents. The current study also suggests that experimental approach using these anesthetics may affect feeding behavior.

1.. Introduction
================

In experimental research, inhalation of Carbon Dioxide (CO~2~) or diethyl ether is used as light anesthetic agents. For example, in our previous studies that we considered the role of the Ventromedial Hypothalamus (VMH) ([@B4]) and paraventricular ([@B2]; [@B7]) hypothalamic orexin-1 receptors in the regulation of gastric acid secretion, the ventromedial hypothalamus VMH or PVN drug injections were performed under brief diethyl ether anesthesia.

In addition, [@B28] considered the cellular events during arthritis-induced hyperalgesia under brief CO~2~ anesthesia. However, little is known about the effect of light anesthetic agents on experimental results. [@B25] demonstrated that rat plasma corticosterone and glucose increased after two minutes exposure to diethyl ether anesthesia. Furthermore, [@B27] showed that a brief exposure to either diethyl ether or CO~2~ affected the plasma corticosterone, glucose, and insulin levels in fed or fasted rats. These data and others ([@B24]) support that light anesthetic agents affect the experimental data.

Recently, the effects of CO~2~ on insects and plants behavior have been shown. For example, [@B15] demonstrated that the take-off and source contact behavior of Aedes aegypti (female yellow fever mosquitoes) is impeded at elevated background levels of CO~2~ as a result of masking of the stimulus signal. Furthermore, saprophagous insects often use CO~2~ as a cue for finding food ([@B9]) and elevated atmospheric CO~2~ increases fiber fractions of a mammalian herbivore, Microtus ochrogaster ([@B5]).

To control the homeostatic feeding motivation, a number of neurons project to hypothalamic Paraventricular Nucleus (PVN) ([@B18]; [@B20]; [@B21]). Dopamine is also considered to be the main catecholamine in the brain and serves an important regulatory role in the control of feeding behavior (Szczypka, Rainey, & Palmiter, 2000; [@B23]). Dopamine signaling is mediated by five receptors, termed D~1~--D~5~ receptors. Administration of D~2~ receptor agonist decreases plasma leptin levels in an obese woman and increases food intake ([@B8]).

Furthermore, according to [@B26] study, D~4~ receptors in PVN may be a pharmacological target for obesity. Recently, we also reported that D~1~ and D~2~ Dopamine Receptors (DR) and also Glucosensitive Neurons (GSNs) in the hypothalamic Paraventricular Nucleus (PVN) increased food intake in 18 hours food-deprived rats (data is preparing to be submitted). In our experiments, dopamine agonists, antagonists and glucose were injected into the hypothalamic Paraventricular Nucleus under light diethyl ether anesthesia. However, little is known about the effect of brief diethyl ether or CO~2~ anesthesia on experimental food intake results. Therefore, in this study, we evaluated whether inhalation of diethyl ether and CO~2~ as light anesthetic agents is able to affect food intake in conscious rats.

Furthermore, we considered and compared the effect of these two anesthetic agents on PVN D~1~ and D~2~ dopamine receptors-induced and glucose-induced food intake in 18 hours food-deprived rats.

2.. Methods
===========

2.1.. Animals
-------------

Male Wistar rats, weighing 220--250 g (Neuroscience Research Center, Tehran, Iran) were housed in 12:12 h light:dark cycle at 22°C--24°C. They were deprived of food, but not water, for 18--20 h prior to experiments.

2.2.. Drugs
-----------

Ketamine (Rotex, Levallois-Perret, France) and xylazine (Alfasan, Woerden, The Netherlands) were used to anaesthetize rats. Quinpirole, SKF38393 and glucose were purchased from Sigma (St Louis, MO, USA).

2.3.. Injection of compounds
----------------------------

Drugs or vehicle were injected in a volume of 0.3 μL into the PVN. The drug injections were performed under brief diethyl ether or CO~2~ anesthesia using a 0.5-μL Hamilton syringe. Animals were exposed to CO~2~ or diethyl ether inhalation for 30 s and obtained full consciousness after 1 minute.

2.4.. Operation
---------------

After anesthetizing by ketamine and xylazine, animals were fitted with a 23-gauge stainless steel cannula. Cannula was inserted into right PVN according to the stereotaxic atlas of [@B19] as follows: lateral, 0.4 mm from midline; dorsoventral, 7 mm from skull surface; and anteroposterior, 1.8 mm from the bregma. The injector was extended 1 mm beyond the end of the guide cannula. Experimental trials were performed after 7-day recovery period. For histological examination, the brains were fixed in formalin and 100-μM thick sections were taken and examined with light microscopy.

2.5.. Measurements of food intake
---------------------------------

The weight of food pellets used were measured by a Sartorius scale, TE3135 (Gottingen, Germany), with d=0.001 mg accuracy. Feeding trials normally conducted from Saturday to Wednesday between 9:00 AM and 12:00 PM. On the test day, the fasted rats were transported to the laboratory at least 1 h before the beginning of the feeding trial. After injecting the test compound, the rats were placed in a clear plastic cage and allowed access to a premeasured amount of their regular lab feeding chow. The amount of food and crumbs left in the test cages was measured. Rats received no more than two feeding trials per week. All experiments were approved by the Research and Ethics Committee of Shahid Beheshti University of Medical Sciences (IR.SBMU. PHNS.REC.1396.33).

2.6.. Statistical analysis
--------------------------

Results are presented as the mean±SEM. The differences between two and more than two groups were evaluated by the Student t test and 1-way ANOVA followed by Tukey HSD test, respectively. P\<0.05 was considered significant.

3.. Results
===========

3.1.. Influence of light CO~2~ and diethyl ether anesthesia on food intake
--------------------------------------------------------------------------

Inhalation of CO~2~ but not diethyl ether (for 30 s) had a significant effect on food intake. After light CO~2~ anesthesia, food intake decreased significantly ([Figure 1](#F1){ref-type="fig"}). Our results indicate a reduction of approximately 20% with a value of 1.71±0.1 g/h from light CO~2~ test group compared to 2.1±0.1 g/h for the control group (n=5) (P\<0.01). Furthermore, [Figure 1](#F1){ref-type="fig"} demonstrates that light diethyl ether anesthesia has no effect on food intake.

![Effects of the light anesthetics on PVN injection of saline in food intake\
Data are presented as mean±SEM (n=5 per group). \*\*\*P\<0.001 compared to saline group; \*\*P\<0.01 compared with saline group (intact animals).](BCN-9-269-g001){#F1}

3.2.. Effects of light CO~2~ and diethyl ether anesthesia on glucose-induced food intake
----------------------------------------------------------------------------------------

Our study showed that the PVN injection of glucose induced dose-dependent increase of gastric acid secretion and glucose 0.8 μg had maximum stimulatory effect ([@B2]). Acid secretion is a part of feeding behavior. As shown in [Figure 2](#F2){ref-type="fig"}, in light CO~2~ test groups, glucose (0.8 μg) did not affect food intake compared to the control rats (animals received saline without anesthetic agents).

![Effects of the light anesthetics on PVN injection of glucose in food intake\
Data are presented as mean±SEM (n=6 per group). \*\*P\<0.01; \*\*\*P\<0.001; \*\*\*\*P\<0.0001 compared to saline group.](BCN-9-269-g002){#F2}

In diethyl ether group, food intake increased from 2.1 g/h in saline group to 2.6±0.08 g/h in glucose 0.8 μg-treated rats (n=5) (P\<0.01). In the absence of anesthetic agents, however, the magnitude of glucose-induced food intake was approximately 2-fold more, compared to the control group ([Figure 2](#F2){ref-type="fig"}).

3.3.. Effects of light CO~2~ and diethyl ether anesthesia on SKF3833 (D~1~ receptor agonist)-induced and quinpirole (D~2~ receptor agonist)-induced food intake
---------------------------------------------------------------------------------------------------------------------------------------------------------------

In our previous study, we showed that PVN-microinjection of SKF38393 and quinpirole increased food in-take in a dose-dependent manner and the maximum effects were observed at doses of 3 and 5 μg, respectively (data is preparing to be submitted). PVN injection of SKF38393 (P\<0.001) or quinpirole (P\<0.01) decreased food intake after light CO~2~ anesthesia ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Compared to CO~2~ group, light diethyl ether anesthesia had reverse effect on D~1~ and D~2~ receptors-induced food intake. As shown in [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}, PVN microinjection of SKF38393 (5 μg) and quinpirole (0.3 μg) increased food intake compared to saline group (P\<0.001 and P\<0.0001, respectively).

![Effects of the light anesthetics on PVN injection of SKF38393 in food intake\
\*\*\*P\<0.001 compared to saline groups.](BCN-9-269-g003){#F3}

![Effects of the light anesthetics on PVN injection of quinpirole in food intake\
\*\*\*\*P\<0.0001; \*\*P\<0.01 compared to saline groups.](BCN-9-269-g004){#F4}

4.. Discussion
==============

In this study, we demonstrated that brief inhalation of CO~2~, but not diethyl ether, as light anesthetic agents, decrease food intake compared to saline-treated rats. Furthermore, in the current study, we found that D~1~ and D~2~ dopamine receptors-induced food intake decreases under light CO~2~ anesthesia. However, despite the negative effect of CO~2~ on D~1~ and D~2~-induced food intake, we observed D~1~ and D~2~ agonist increased feeding behavior under brief diethyl ether anesthesia. Our result has also shown that glucose-stimulated food intake has remained at high level under light diethyl ether anesthesia similar to intact animals (without light anesthetic agents). However, this effect was not observed in CO~2~ group with the same drug condition.

The hypothalamic Paraventricular Nucleus (PVN) receives a number of central pathways to control the eating behavior ([@B1]; [@B18]; [@B21]). These studies have demonstrated that the neuropeptides and neurotransmitters are involved in these phenomena. For example, anorectic agent induces its effects through the cerebral release of dopamine, and the consequent activation of D~1~-like and D~2~-like receptors ([@B13]; [@B3]; [@B10]; [@B11]), decreasing the level of hypothalamic Neuropeptide Y (NPY) (Hsie, Yang, & [@B12]; [@B12]). Furthermore, we have shown that PVN-microinjected SKF38393 (a dopamine D~1~ agonist) and quinpirole (a dopamine D~2~ agonist) increased food intake at doses more than 0.07 μg. These effects were inhibited by D~1~ and D~2~ dopamine receptor antagonists, SCH23390 and sulpiride, respectively (data are preparing to be submitted).

Within the hypothalamus, glucosensitive neurons are found in the arcuate and paraventricular nuclei ([@B22]). Our results showed that the PVN-microinjected glucose increased gastric acid secretion at doses of 350--750 nM in 18--24 h fasted conscious rats ([@B2]). Gastric acid secretion is a part of feeding behavior. Therefore, we suggest that the PVN-glucose sensing neurons might be involved in central regulatory mechanism of acid secretion and the control of energy homeostasis.

All our experiments were done under brief diethyl ether anesthesia. Although it is well established that PVN D~1~ and D~2~ dopamine receptors and glucosensing neurons are involved in regulatory mechanisms of feeding behavior, the specific effects of inhalation of light anesthetic agents including CO~2~ and diethyl ether during experimental approaches have remained unexplored. Our results show that glucose and D~1~ and D~2~ agonists increase food intake under brief diethyl ether anesthesia whereas light CO~2~ inhalation inhibits the effect of glucose and changes the stimulatory effects of D~1~ and D~2~ agonists to inhibitory effects in feeding behavior. At the present time, we do not know the exact CO~2~ and diethyl ether mechanisms on food intake.

Probably the food intake decreases under brief anesthesia as a result of masking of the stimulus signal. For example, PVN and lateral hypothalamus received NPY-containing neuron projections from arcuate nucleus. It has been shown that NPY increases food intake by activating NPY1 and NPY5 receptors within the hypothalamus ([@B14]; [@B16]). Furthermore, our previous studies indicate that the orexin-A-induced gastric acid secretion in PVN ([@B2]) is blocked by Intracerebroventricular (ICV) administration of NPY1- and NPY5-receptor antagonists ([@B7]).

Gastric acid secretion is a part of feeding behavior. [@B17] demonstrated that afferent information from the autonomic nervous system affects gastrointestinal mediators, and circulatory concentrations of nutrients and hormones are transmitted to the presynaptic monoaminergic system of the hypothalamus. These presynaptic afferent neurons influence postsynaptic cells by releasing dopamine. According to their model, post-synaptic neurons may express both D~1~ and D~2~ receptors which are involved in food intake by activation of stimulatory and inhibitory food intake neuropeptides, including NPY. Therefore, we suggest that masking of the first or second order hypothalamic neurons in response to the light anesthetic agents may be one mechanism by which food intake decreases.

In conclusion, the present study demonstrates that light CO~2~ but not diethyl ether anesthetics decreases food in-take. Our results suggest that dopamine receptors and glucosensing neurons in PVN may be, at least in part, one of targets of light anesthetic agents. Whether these effects result from masking of inhibitory or stimulatory neurons which originate in the PVN or is mediated by fibers of passage is yet to be determined. The current study also suggests that feeding experimental results may be affected by any experimental approach using these anesthetics
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